1144
mixture was stirred for 15 min, then (S)-N-(tert-butoxycarbonyl)homoserine lactone12 (224 mg, 1.11
mmol) in CH2Cl2 (3 mL) was added slowly and stirring was continued at ambient temperature for 18
h. The reaction was quenched carefully with 10% aqueous citric acid (1 mL) and, after effervescence
had stopped, the mixture was partitioned between saturated aqueous potassium sodium tartrate (10 mL)
and CH2Cl2 (10 mL). The aqueous layer was extracted further with CH2Cl2 (2×10 mL). The combined
organic extracts were dried over Na2SO4, filtered, and concentrated in vacuo. The crude product was
purified by flash column chromatography on silica, eluting with a gradient of EtOAc–20 to 10% hexane
to yield the amide as an oil (221 mg, 67%). 1H NMR (CDCl3) δ 9.69 (1H, br s), 8.31 (1H, dd, J=4.8, 0.9
Hz), 8.20 (1H, d, J=8.1 Hz), 7.70 (1H, ddd, J=8.4, 7.3, 1.8 Hz), 7.04 (1H, ddd, J=7.3, 4.9, 0.9 Hz), 6.05
(1H, br d, J=5.1 Hz), 4.62 (1H, m), 3.93 (1H, m), 3.79 (2H, m), 2.14 (1H, m), 1.96 (1H, m), 1.48 (9H, s).
MS (EI) m/z=295 (M+=C14H21N3O4). HPLC purity=91.7% (215 nm).
(S)-3-(tert-Butoxycarbonylamino)-2-oxo-1-(2-pyridyl)pyrrolidine (3a). Tri-n-butylphosphine (0.208
mL, 0.83 mmol) was added to a solution of di-tert-butyl azodicarboxylate (191 mg, 0.83 mmol) in dry
THF (2 mL) at ambient temperature. The resulting mixture was stirred for 5 min, then added dropwise
to a solution of (S)-2-(tert-butoxycarbonylamino)-4-hydroxy-N-pyridin-2-ylbutyramide (190 mg, 0.64
mmol) in THF (1 mL) at 0°C, under argon. The reaction mixture was allowed to warm slowly to
ambient temperature and stirred for 18 h, then partitioned between saturated aqueous NaHCO3 (5 mL)
and CH2Cl2 (10 mL). The aqueous layer was extracted further with CH2Cl2 (10 mL). The combined
organic extracts were dried over Na2SO4, filtered, and concentrated in vacuo. The crude product was
purified by flash column chromatography on silica, eluting with a gradient of hexane–20 to 40% EtOAc
1
to yield the lactam as a white solid (169 mg, 95%). H NMR (CDCl3) δ 8.38 (1H, d, J=8.4 Hz), 8.37
(1H, ddd, J=4.8, 1.8, 0.7 Hz), 7.71 (1H, ddd, J=8.5, 7.3, 2.0 Hz), 7.06 (1H, ddd, J=7.2, 4.9, 0.9 Hz), 5.16
(1H, br s), 4.42 (1H, m), 4.27 (1H, dd, J=11.0, 9.2 Hz), 3.82 (1H, td, J=11.1, 6.4 Hz), 2.75 (1H, m), 1.91
(1H, m), 1.44 (9H, s). MS (EI) m/z=277 (M+=C14H19N3O3). HRMS (EI) calculated for C14H19N3O3
m/z=277.1426; found m/z=277.1425. HPLC purity=100.0% (215 nm). Mosher amide analysis of this
product by 1H NMR indicated less than 0.5% of the undesired isomer.13
Acknowledgements
The authors thank Neville Anthony, Chris Dinsmore, and George Hartman for critical reading of the
manuscript, Joan Murphy and Steve Pitzenberger for NMR spectroscopy expertise, Art Coddington, Harri
Ramjit, and Charles W. Ross III for mass spectral analyses, Joanne Kinneary for literature searches, and
Joy Hartzell for manuscript preparation.
References
1. Freidinger, R. M.; Veber, D. F.; Perlow, D. S.; Brooks, J. R.; Saperstein, R. Science 1980, 210, 656.
2. Aube, J. Adv. Amino Acid Mimetics and Peptidomimetics 1997, 1, 193.
3. Freidinger, R. M.; Perlow, D. S.; Veber, D. F. J. Org. Chem. 1982, 47, 104.
4. (a) Kurihara, T.; Nakajima, Y.; Mitsunobu, O. Tetrahedron Lett. 1976, 2455. (b) Mitsunobu, O. Synthesis 1981, 1.
5. Weissman, S. A.; Lewis, S.; Askin, D.; Volante, R. P.; Reider, P. J. Tetrahedron Lett. 1998, 39, 7459.
6. Townsend, C. A.; Nguyen, L. T. J. Am. Chem. Soc. 1981, 103, 4582.
7. (a) Hinds, M. G.; Richards, N. G. J.; Robinson, J. A. J. Chem. Soc., Chem. Commun. 1988, 1447. (b) Genin, M. J.; Gleason,
W. B.; Johnson, R. L. J. Org. Chem. 1993, 58, 860. (c) Genin, M. J.; Ojala, W. H.; Gleason, W. B.; Johnson, R. L. J. Org.
Chem. 1993, 58, 2334. (d) Hadfield, P. S.; Galt, R. H. B.; Sawyer, Y.; Layland, N. J.; Page, M. I. J. Chem. Soc., Perkin Trans.
1 1997, 503. (e) Chu, W.; Perlman, J. H.; Gershengorn, M. C.; Moeller, K. D. Bioorg. Med. Chem. Lett. 1998, 8, 3093.